Analgesic Strategies After Mastectomy: RIB vs RIB + DPIPB
Starting soon
Conditions studied: Postoperative Pain
In brief
This retrospective observational study evaluates postoperative pain outcomes in patients undergoing elective mastectomy who received systemic analgesia, rhomboid intercostal block (RIB), or combined rhomboid intercostal block with deep parasternal intercostal plane block (RIB + DPIPB). Medical records from October 2024 to October 2025 will be reviewed. Primary outcomes include pain scores within the first 24 hours, with secondary outcomes including opioid consumption, additional analgesic requirements, patient satisfaction, and early postoperative complications. All data will be analyzed retrospectively and anonymously.
Key facts
- Study ID
- NCT07401602
- Run by
- Istinye University
- People needed
- 66
- Starts
- 2026-02-10
- Expected to finish
- 2026-03-20
- Last updated by the study team
- 2026-02-10
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Female patients aged 18-70 years
- Elective mastectomy performed between October 2024 and October 2025
- ASA physical status I-III
- Complete postoperative pain and analgesia records for the first 24 hours
- Clearly documented analgesic technique (systemic analgesia, RIB, or RIB + DPIPB)
You may not qualify if…
- Incomplete or missing medical records
- Emergency mastectomy or emergency surgery
- Reoperation within the first 24 hours postoperatively
- Major intraoperative complications preventing standard analgesia
- Neurological or psychiatric conditions interfering with pain assessment
Where it is running
- Istinye Üniversity — Istanbul, Merkez Mahallesi, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.